"J Cyst Fibros"[jour] - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 654

<< First< Prev

Page of 33

Next >Last >>

Select item 114097691.

Demographic factors associated with within-individual variability of lung function for adults with cystic fibrosis: A UK registry study

Marco Palma, Ruth H Keogh, Siobhán B Carr, Rhonda Szczesniak, David Taylor-Robinson, Angela M Wood, Graciela Muniz-Terrera, Jessica K Barrett

J Cyst Fibros. 2024 Sep; 23(5): 936–942. doi: 10.1016/j.jcf.2024.05.013

PMCID:: PMC11409769

Article

Select item 111827172.

ALTERATIONS IN THE FECAL MICROBIOTA IN PATIENTS WITH ADVANCED CYSTIC FIBROSIS LIVER DISEASE AFTER 6 MONTHS OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR

Duong Jennifer T, Pope Christopher E, Hayden Hillary S, Miller Carson, Salipante Stephen J, Rowe Steven M, Solomon George M, Nichols David, Hoffman Lucas R, Narkewicz Michael R, Green Nicole

J Cyst Fibros. Author manuscript; available in PMC 2024 Aug 1.

Published in final edited form as: J Cyst Fibros. 2024 May; 23(3): 490–498. Published online 2024 Mar 6. doi: 10.1016/j.jcf.2024.02.015

PMCID:: PMC11182717

Article PDF–1.4M

Select item 109483043.

A longitudinal analysis of respiratory symptoms in people with cystic fibrosis with advanced lung disease on and off ETI

Eliana R. Gill, Lauren E. Bartlett, Tijana Milinic, Nora Burdis, Joseph M. Pilewski, Jordan M. Dunitz, Siddhartha G. Kapnadak, Christopher H. Goss, Kathleen J. Ramos

J Cyst Fibros. Author manuscript; available in PMC 2025 Jan 1.

Published in final edited form as: J Cyst Fibros. 2024 Jan; 23(1): 161–164. Published online 2023 Nov 25. doi: 10.1016/j.jcf.2023.11.008

PMCID:: PMC10948304

Article PDF–170K

Select item 114809984.

THE RELATIONSHIP BETWEEN THE INTESTINAL MICROBIOME AND BODY MASS INDEX IN CHILDREN WITH CYSTIC FIBROSIS

Rachel Bernard, Meghan H. Shilts, Britton A. Strickland, Helen H. Boone, Daniel C. Payne, Rebekah F. Brown, Kathryn Edwards, Suman R. Das, Maribeth R. Nicholson

J Cyst Fibros. Author manuscript; available in PMC 2025 Mar 1.

Published in final edited form as: J Cyst Fibros. 2024 Mar; 23(2): 242–251. Published online 2023 Nov 11. doi: 10.1016/j.jcf.2023.11.002

PMCID:: PMC11480998

Article PDF–822K

Select item 110764175.

Identification of Prognostic Biomarkers for Antibiotic Associated Nephrotoxicity in Cystic Fibrosis

Andrew Hart, Francine Cesar, Leila R Zelnick, Nick O’Connor, Zoie Bailey, Jordan Lo, Kirk Van Ness, Ian B. Stanaway, Theo K. Bammler, James W. MacDonald, Matthew R. Thau, Jonathan Himmelfarb, Christopher H. Goss, Moira Aitken, Edward J. Kelly, Pavan K. Bhatraju

J Cyst Fibros. Author manuscript; available in PMC 2024 Jun 1.

Published in final edited form as: J Cyst Fibros. 2024 Mar; 23(2): 293–299. Published online 2023 Nov 10. doi: 10.1016/j.jcf.2023.10.021

PMCID:: PMC11076417

Article PDF–777K

Select item 109483166.

EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON MUCUS AND MUCOCILIARY CLEARANCE IN CYSTIC FIBROSIS

Scott H. Donaldson, Timothy E. Corcoran, Joseph M. Pilewski, Peter Mogayzel, Beth L. Laube, Evan R. Boitet, Elex S. Harris, Agathe Ceppe, Lloyd J. Edwards, Kirby Zeman, Jihong Wu, Charles R. Esther, Jr., David P. Nichols, William D. Bennett, Steven M. Rowe

J Cyst Fibros. Author manuscript; available in PMC 2025 Jan 1.

Published in final edited form as: J Cyst Fibros. 2024 Jan; 23(1): 155–160. Published online 2023 Oct 14. doi: 10.1016/j.jcf.2023.10.010

PMCID:: PMC10948316

Article PDF–576K

Select item 108030627.

ALTERATIONS IN LIPIDS AFTER INITIATION OF HIGHLY EFFECTIVE MODULATORS IN PEOPLE WITH CYSTIC FIBROSIS

Katherine A. Despotes, Agathe S. Ceppe, Scott H. Donaldson

J Cyst Fibros. Author manuscript; available in PMC 2024 Nov 1.

Published in final edited form as: J Cyst Fibros. 2023 Nov; 22(6): 1024–1026. Published online 2023 Oct 12. doi: 10.1016/j.jcf.2023.10.002

PMCID:: PMC10803062

Article PDF–119K

Select item 109951018.

Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location

Laura S. Gold, Ryan N. Hansen, Sonya L. Heltshe, Patrick A. Flume, Christopher H. Goss, Natalie E. West, Don B. Sanders, Larry Kessler

J Cyst Fibros. Author manuscript; available in PMC 2025 Mar 1.

Published in final edited form as: J Cyst Fibros. 2024 Mar; 23(2): 278–281. Published online 2023 Oct 5. doi: 10.1016/j.jcf.2023.10.004

PMCID:: PMC10995101

Article PDF–100K

Select item 109490879.

Longitudinal bacterial prevalence in cystic fibrosis airways: fact and artifact

D.R. VanDevanter, J.J. LiPuma, M.W. Konstan

J Cyst Fibros. Author manuscript; available in PMC 2025 Jan 1.

Published in final edited form as: J Cyst Fibros. 2024 Jan; 23(1): 58–64. Published online 2023 Oct 1. doi: 10.1016/j.jcf.2023.09.011

PMCID:: PMC10949087

Article PDF–1.1M

Select item 1084301010.

SNSP113 (PAAG) Improves Mucociliary Transport and Lung Pathology in the Scnn1b-Tg Murine Model of CF Lung Disease

Elex S. Harris, Lea Novak, Courtney M. Fernandez-Petty, Natalie R. Lindgren, Shenda M. Baker, Susan E. Birket, Steven M. Rowe

J Cyst Fibros. Author manuscript; available in PMC 2024 Nov 1.

Published in final edited form as: J Cyst Fibros. 2023 Nov; 22(6): 1104–1112. Published online 2023 Sep 14. doi: 10.1016/j.jcf.2023.08.011

PMCID:: PMC10843010

Article PDF–902K

Select item 1084306311.

Red ginseng aqueous extract improves mucociliary transport dysfunction and histopathology in CF rat airways

Do-Yeon Cho, Shaoyan Zhang, Daniel Skinner, Connor G. Koch, Metta J. Smith, Dong-Jin Lim, Jessica W. Grayson, Guillermo J. Tearney, Steven M. Rowe, Bradford A. Woodworth

J Cyst Fibros. Author manuscript; available in PMC 2024 Nov 1.

Published in final edited form as: J Cyst Fibros. 2023 Nov; 22(6): 1113–1119. Published online 2023 Sep 12. doi: 10.1016/j.jcf.2023.09.002

PMCID:: PMC10843063

Article PDF–805K

Select item 1090754412.

PRospective Evaluation of Nontuberculous Mycobacteria Disease in CysTic Fibrosis: The design of the PREDICT study

Stacey L. Martiniano, Silvia M. Caceres, Katie Poch, Noel M. Rysavy, Valerie K. Lovell, Emily Armantrout, Marion Jones, Margaret Anthony, Allison Keck, David P. Nichols, Jill M. Vandalfsen, Scott D. Sagel, Brandie Wagner, Jing Xie, Katie Weaver, Sonya L. Heltshe, Charles L. Daley, Rebecca M. Davidson, Jerry A. Nick, Investigators of the Cystic Fibrosis NTM Consortium

J Cyst Fibros. Author manuscript; available in PMC 2025 Jan 1.

Published in final edited form as: J Cyst Fibros. 2024 Jan; 23(1): 50–57. Published online 2023 Sep 4. doi: 10.1016/j.jcf.2023.08.007

PMCID:: PMC10907544

Article PDF–722K

Select item 1089128913.

PANCREATIC DUCT ORGANOID SWELLING IS CHLORIDE-DEPENDENT

Yunxia O’Malley, Keyan Zarei, Oriana G. Calderon Vanegas, Pratibha Singh, T. Idil Apak, Mitchell Coleman, Ian M. Thornell, Aliye Uc

J Cyst Fibros. Author manuscript; available in PMC 2025 Jan 1.

Published in final edited form as: J Cyst Fibros. 2024 Jan; 23(1): 169–171. Published online 2023 Aug 24. doi: 10.1016/j.jcf.2023.08.003

PMCID:: PMC10891289

Article PDF–369K

Select item 1084067914.

The association between gut microbiome and growth in infants with cystic fibrosis

Deschamp AR, Chen Y, Wang WF, Rasic M, Hatch J, Sanders DB, Ranganathan SC, Ferkol T, Perkins D, Finn P, Davis SD

J Cyst Fibros. Author manuscript; available in PMC 2024 Nov 1.

Published in final edited form as: J Cyst Fibros. 2023 Nov; 22(6): 1010–1016. Published online 2023 Aug 17. doi: 10.1016/j.jcf.2023.08.001

PMCID:: PMC10840679

Article PDF–969K

Select item 1084377215.

THE IMPACT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON FAT-SOLUBLE VITAMIN LEVELS IN PEOPLE WITH CYSTIC FIBROSIS

Georgene E. Hergenroeder, Anna Faino, Gracia Bridges, Lauren E. Bartlett, Jonathan D. Cogen, Nicole Green, Sharon McNamara, David P. Nichols, Kathleen J. Ramos

J Cyst Fibros. Author manuscript; available in PMC 2024 Nov 1.

Published in final edited form as: J Cyst Fibros. 2023 Nov; 22(6): 1048–1053. Published online 2023 Aug 8. doi: 10.1016/j.jcf.2023.08.002

PMCID:: PMC10843772

Article PDF–239K

Select item 1080283916.

Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis

Meghan E. McGarry, Chiung-Yu Huang, Ngoc P. Ly

J Cyst Fibros. Author manuscript; available in PMC 2024 Jan 22.

Published in final edited form as: J Cyst Fibros. 2023 Sep; 22(5): 909–915. Published online 2023 Jul 16. doi: 10.1016/j.jcf.2023.07.004

PMCID:: PMC10802839

Article PDF–946K

Select item 1077680217.

Changes in Nutrition and Growth Status in Young Children in the First 12 Weeks of Ivacaftor Therapy

Alyssa Tindall, Rosara Bass, Asim Maqbool, Virginia A. Stallings

J Cyst Fibros. Author manuscript; available in PMC 2024 Nov 1.

Published in final edited form as: J Cyst Fibros. 2023 Nov; 22(6): 989–995. Published online 2023 Jul 10. doi: 10.1016/j.jcf.2023.04.010

PMCID:: PMC10776802

Article PDF–384K

Select item 1076158718.

Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis

Oliver J. McElvaney, Sonya L. Heltshe, Katherine Odem-Davis, Natalie E. West, Don B. Sanders, Barbra Fogarty, Donald R. VanDevanter, Patrick A. Flume, Christopher H. Goss

J Cyst Fibros. Author manuscript; available in PMC 2024 Sep 1.

Published in final edited form as: J Cyst Fibros. 2023 Sep; 22(5): 875–879. Published online 2023 Jul 6. doi: 10.1016/j.jcf.2023.06.012